(Q53563482)

15 May 2018

title

BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. (English)

1 reference

15 May 2018

1 reference

Yuli C

1

1 reference

15 May 2018

Shao N

2

1 reference

15 May 2018

Rao R

3

1 reference

15 May 2018

Aysola P

4

1 reference

15 May 2018

Reddy V

5

1 reference

15 May 2018

Oprea-llies G

6

1 reference

15 May 2018

Lee L

7

1 reference

15 May 2018

Okoli J

8

1 reference

15 May 2018

Partridge E

9

1 reference

15 May 2018

Reddy ES

10

1 reference

15 May 2018

Rao VN

11

1 reference

15 May 2018

language of work or name

English

0 references

publication date

26 March 2007

1 reference

15 May 2018

published in

Oncogene

1 reference

15 May 2018

volume

26

1 reference

15 May 2018

page(s)

6031-6037

1 reference

15 May 2018

issue

41

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210420

exact match

0 references

cites work

Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

The basal phenotype of BRCA1-related breast cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

BRCA1-associated growth arrest is RB-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Emerging roles of BRCA1 alternative splicing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 regulates p53-dependent gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 carries tumor suppressor activity distinct from that of p53 and p21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 gene in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Preclinical studies of a new generation retroviral vector for ovarian cancer BRCA1 gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 interacts with components of the histone deacetylase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210420

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210420

1 reference

15 May 2018

PubMed ID

17384678

1 reference

15 May 2018